Exane Derivatives’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Exane Derivatives’s Portfolio MSOS Stock Details MSOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$15.1K	Hold	1,460	–	–	0.01%	376
2022 Q1	$30.5K	Sell	1,460 -35,000	-96%	-$764K	0.01%	626
2021 Q4	$933K	Buy	+36,460	New	+$1.01M	0.23%	100

Other funds holding MSOS

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

ZIG

Zuckerman Investment Group Chicago, Illinois $1.18B AUM 22.58% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

SCP

Sender Company & Partners New York $345M AUM 41.88% 1-Year Est. Return

Parallax Volatility Advisers San Francisco, California $58.9B AUM 51.73% 1-Year Est. Return

Exane Derivatives's MSOS Position: Q2 2022 in Review

Exane Derivatives held its AdvisorShares Pure US Cannabis ETF (MSOS) position steady in Q2 2022 at 1,460 shares worth $15.1K. The position accounts for 0.01% of the portfolio, ranked #376.

Exane Derivatives first reported a position in MSOS in Q4 2021 and has held it in 3 quarters since. The position peaked at $933K in Q4 2021. 168 funds tracked by Wall St. Rank hold MSOS as of Q2 2022.

Exane Derivatives held 1,460 shares of AdvisorShares Pure US Cannabis ETF worth $15.1K as of Q2 2022.
Exane Derivatives left its AdvisorShares Pure US Cannabis ETF share count unchanged in Q2 2022.
AdvisorShares Pure US Cannabis ETF made up 0.01% of Exane Derivatives's portfolio in Q2 2022, its #376 holding.
Exane Derivatives first reported a position in AdvisorShares Pure US Cannabis ETF in Q4 2021 and has held it in 3 quarters since.
Exane Derivatives's AdvisorShares Pure US Cannabis ETF position peaked at $933K in Q4 2021.
168 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.